Seeing Is Believing
MBRX is currently covered by 1 analysts with an average price target of $22. This is a potential upside of $-15.21 (2550.6%) from yesterday's end of day stock price of $0.83.
Moleculin Biotech's activity chart (see below) currently has 9 price targets and 14 ratings on display. The stock rating distribution of MBRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 226 days.
Highest price target for MBRX is $22, Lowest price target is $22, average price target is $22.
Most recent stock forecast was given by from HC WAINWRIGHT on 24-Mar-2026. First documented stock forecast 17-Oct-2019.
Currently out of the existing stock ratings of MBRX, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2025
$22
$18.73 (572.78%)
$4
5 months 18 days ago
(24-Mar-2026)
1/2 (50%)
$19.75 (877.78%)
99
Buy Since 09-Jun-2025
$4
$0.73 (22.32%)
$4
1 years 2 months 24 days ago
(18-Jun-2025)
2/2 (100%)
$-10.58 (-72.57%)
188
Buy Since 14-Dec-2023
$8
1 years 5 months 17 days ago
(25-Mar-2025)
3/3 (100%)
$-18.5 (-69.81%)
190
Hold Since 25-Mar-2025
$4
$0.73 (22.32%)
1 years 5 months 17 days ago
(25-Mar-2025)
1/1 (100%)
$-24.75 (-86.09%)
268
Buy Since 14-Apr-2021
$30
$26.73 (817.43%)
2 years 28 days ago
(14-Aug-2024)
3/3 (100%)
$-32.5 (-52.00%)
380
What is MBRX (Moleculin Biotech) average time for price targets to be met?
Which analyst most recently updated their price target on MBRX (Moleculin Biotech)?
Which analyst has the most public recommendations on MBRX (Moleculin Biotech)?
Which analyst is the currently most bullish on MBRX (Moleculin Biotech)?
Which analyst is the currently most reserved on MBRX (Moleculin Biotech)?